# 3D pentaculture model unveils malignant cell-driven macrophage polarization in high-grade serous ovarian cancer

**Authors:** Beatrice Malacrida, Samar Elorbany, Florian Laforêts, Faisal Karim, Rachel C. Bryan-Ravenscroft, Michail Sideris, Joash D. Joy, Panoraia Kotantaki, Sophie L. P. Skingsley, Owen M. Heath, Ranjit Manchanda, Eleni Maniati, Frances R. Balkwill

PMC · DOI: 10.1038/s41467-026-70398-z · 2026-03-25

## TL;DR

A 3D lab model of ovarian cancer shows how cancer cells influence immune cells called macrophages in the tumor environment.

## Contribution

A novel 3D pentaculture model reveals malignant cell-driven macrophage polarization in HGSOC.

## Key findings

- Macrophage clusters in the model match those in human HGSOC metastases.
- Malignant cell heterogeneity influences macrophage activity and tumor environment.
- Anti-CD47 and anti-CD24 antibodies affect macrophage behavior and cancer cell viability.

## Abstract

High-grade serous ovarian cancer (HGSOC) is characterized by a complex, immunosuppressive tumor microenvironment (TME) that contributes to poor clinical outcomes and resistance to therapy. To replicate the human TME in vitro, we develop a 3D pentaculture model incorporating five human cell types: malignant HGSOC cells and primary fibroblasts, mesothelial cells, adipocytes, monocytes. Monocytes differentiate into macrophages without exogenous cytokines in the pentacultures. Bulk RNA sequencing and deconvolution with single-cell RNA data from patient biopsies reveal that macrophage clusters within the pentacultures replicate those found in human HGSOC metastases, and proportions of individual clusters vary according to the malignant cell line. The pentacultures enable detailed analysis of malignant cell–macrophage interactions and highlight the influence of malignant cell genomic, transcriptomic and proteomic heterogeneity on the TME. Furthermore, targeting of “do-not-eat-me” signals with anti-CD47 and anti-CD24 monoclonal antibodies demonstrate differential effects on macrophage activity and cancer cell viability, again depending on the individual malignant cell line. Real-time microscopic monitoring of the pentacultures confirms dynamic modulation of macrophage behavior. We conclude that this pentaculture model offers a platform to study malignant cell control of TME elements and in particular their interactions with myeloid cells.

High-grade serous ovarian cancer (HGSOC) is characterised by a complex tumour microenvironment contributing to poor clinical outcomes and resistance to therapy. Here, the authors develop a 3D pentaculture in vitro model of HGSOC incorporating five human cell types, revealing how malignant cells drive macrophage polarisation and influence the tumour microenvironment.

## Linked entities

- **Proteins:** CD47 (CD47 molecule), CD24 (CD24 molecule)
- **Diseases:** ovarian cancer (MONDO:0005140)

## Full-text entities

- **Genes:** CD163 (CD163 molecule) [NCBI Gene 9332] {aka M130, MM130, SCARI1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, CSF1R (colony stimulating factor 1 receptor) [NCBI Gene 1436] {aka BANDDOS, C-FMS, CD115, CSF-1R, CSFR, FIM2}, SIGLEC1 (sialic acid binding Ig like lectin 1) [NCBI Gene 6614] {aka CD169, SIGLEC-1, SN}, COL14A1 (collagen type XIV alpha 1 chain) [NCBI Gene 7373] {aka UND}, RB1 (RB transcriptional corepressor 1) [NCBI Gene 5925] {aka OSRC, PPP1R130, RB, p105-Rb, p110-RB1, pRb}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, IL33 (interleukin 33) [NCBI Gene 90865] {aka C9orf26, DVS27, IL1F11, NF-HEV, NFEHEV}, TGFBR1 (transforming growth factor beta receptor 1) [NCBI Gene 7046] {aka AAT5, ACVRLK4, ALK-5, ALK5, ESS1, LDS1}, FANCA (FA complementation group A) [NCBI Gene 2175] {aka FA, FA-H, FA1, FAA, FACA, FAH}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}, CXCL9 (C-X-C motif chemokine ligand 9) [NCBI Gene 4283] {aka CMK, Humig, MIG, SCYB9, crg-10}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, AP2B1 (adaptor related protein complex 2 subunit beta 1) [NCBI Gene 163] {aka ADTB2, AP105B, AP2-BETA, CLAPB1}, COL27A1 (collagen type XXVII alpha 1 chain) [NCBI Gene 85301] {aka STLS}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CCNE1 (cyclin E1) [NCBI Gene 898] {aka CCNE, pCCNE1}, EEF1A2 (eukaryotic translation elongation factor 1 alpha 2) [NCBI Gene 1917] {aka DEE33, EEF1AL, EF-1-alpha-2, EF1A, EIEE33, HS1}, VCAN (versican) [NCBI Gene 1462] {aka CSPG2, ERVR, GHAP, PG-M, WGN, WGN1}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, BRCA2 (BRCA2 DNA repair associated) [NCBI Gene 675] {aka BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD}, GPNMB (glycoprotein nmb) [NCBI Gene 10457] {aka HGFIN, NMB, PLCA3}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, ITGB3 (integrin subunit beta 3) [NCBI Gene 3690] {aka BDPLT16, BDPLT2, BDPLT24, CD61, FMAIT1, GP3A}, SIRPA (signal regulatory protein alpha) [NCBI Gene 140885] {aka BIT, CD172A, MFR, MYD-1, MYD1, P84}, CDC73 (cell division cycle 73) [NCBI Gene 79577] {aka C1orf28, FIHP, HPTJT, HRPT1, HRPT2, HYX}, CD24 (CD24 molecule) [NCBI Gene 100133941] {aka CD24A}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, RAD51D (RAD51 paralog D) [NCBI Gene 5892] {aka BROVCA4, R51H3, RAD51L3, TRAD}, THY1 (Thy-1 cell surface antigen) [NCBI Gene 7070] {aka CD90, CDw90}, SIGLEC10 (sialic acid binding Ig like lectin 10) [NCBI Gene 89790] {aka PRO940, SIGLEC-10, SLG2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CD14 (CD14 molecule) [NCBI Gene 929], CD47 (CD47 molecule) [NCBI Gene 961] {aka IAP, MER6, OA3}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, CDK12 (cyclin dependent kinase 12) [NCBI Gene 51755] {aka CRK7, CRKR, CRKRS}, MMP10 (matrix metallopeptidase 10) [NCBI Gene 4319] {aka SL-2, STMY2}, AKT2 (AKT serine/threonine kinase 2) [NCBI Gene 208] {aka HIHGHH, PKBB, PKBBETA, PRKBB, RAC-BETA}, ALDH1A1 (aldehyde dehydrogenase 1 family member A1) [NCBI Gene 216] {aka ALDC, ALDH-E1, ALDH1, ALDH11, HEL-9, HEL-S-53e}, FAP (fibroblast activation protein alpha) [NCBI Gene 2191] {aka DPPIV, FAPA, FAPalpha, SIMP}, CSF1 (colony stimulating factor 1) [NCBI Gene 1435] {aka CSF-1, MCSF, PG-M-CSF}, CXCL12 (C-X-C motif chemokine ligand 12) [NCBI Gene 6387] {aka IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CALB2 (calbindin 2) [NCBI Gene 794] {aka CAB29, CAL2, CR}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}
- **Diseases:** metastases (MESH:D009362), CIN (MESH:D043171), toxicity (MESH:D064420), Cancer (MESH:D009369), macrophage (MESH:D055501), inflammatory (MESH:D007249), HGSOC (MESH:D010051), HRD (MESH:C535296)
- **Chemicals:** L-glutamine (MESH:D005973), SB431542 (MESH:C459179), ethanol (MESH:D000431), Triton X-100 (MESH:D017830), agarose (MESH:D012685), BPS-78932-P (-), streptomycin (MESH:D013307), G164 (MESH:C108733), sodium deoxycholate (MESH:D003840), xylene (MESH:D014992), sialic acid (MESH:D019158), magrolimab (MESH:C000629291), EDTA (MESH:D004492), F12 (MESH:C007782), DAB (MESH:C000469), phenol red (MESH:D010637), DAPI (MESH:C007293), Glutamax (MESH:C054122), platinum (MESH:D010984), PBS (MESH:D007854), methanol (MESH:D000432), penicillin (MESH:D010406), H2O2 (MESH:D006861), paraffin (MESH:D010232), formalin (MESH:D005557), taxane (MESH:C080625), TBS-T (MESH:C027647), Tween-20 (MESH:D011136), DPBS (MESH:C012939), CO2 (MESH:D002245)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Mycoplasma (genus) [taxon 2093]
- **Mutations:** K15054D
- **Cell lines:** AOCS1 — Mus musculus (Mouse), Hybridoma (CVCL_C7RB), LSR — Rattus norvegicus (Rat), Rat sarcoma, Cancer cell line (CVCL_0J67), HTB-161 — Mus musculus (Mouse), Hybridoma (CVCL_A8FQ), HY-P99176 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_A1NX), fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), OvCAR3 — Homo sapiens (Human), High grade ovarian serous adenocarcinoma, Cancer cell line (CVCL_0465), G164 — Homo sapiens (Human), I-cell disease, Finite cell line (CVCL_CX26)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13018538/full.md

---
Source: https://tomesphere.com/paper/PMC13018538